Basilea Pharmaceutica
BSLN.SW
#6003
Rank
NZ$1.94 B
Marketcap
NZ$157.10
Share price
-0.28%
Change (1 day)
48.89%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2025: NZ$0.10 Billion

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are NZ$0.29 Billion. In 2025 the company made an earning of NZ$0.10 Billion a decrease over its 2024 earnings that were of NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2025

Annual earnings

Year Earnings Change
2025NZ$0.10 B-13.15%
2024NZ$0.12 B436.2%
2023NZ$22.64 M-5.02%
2022NZ$23.83 M-276.18%
2021-NZ$13.54 Million-55.31%
2020-NZ$30.28 Million-28%
2019-NZ$42.05 Million-27.06%
2018-NZ$57.66 Million62.13%
2017-NZ$35.56 Million-60.94%
2016-NZ$91.03 Million-19.67%
2015-NZ$0.12 Billion48.25%
2014-NZ$76.44 Million12.95%
2013-NZ$67.68 Million-35.16%
2012-NZ$0.11 Billion-5.75%
2011-NZ$0.12 Billion-152.57%
2010NZ$0.21 B-199.59%
2009-NZ$0.22 Billion-15.54%
2008-NZ$0.26 Billion22.84%
2007-NZ$0.21 Billion60.07%
2006-NZ$0.13 Billion85.69%
2005-NZ$68.6 Million-43.04%
2004-NZ$0.13 Billion47.04%
2003-NZ$81.9 Million-37.04%
2002-NZ$0.14 Billion